✦ LIBER ✦

903 ORAL Clinical activity of single agent pertuzumab (rhuMab 2C4), a HER dimerization inhibitor, in advanced ovarian cancer (OC): potential predictive relationship with tumor HER2 activation status

Book ID: 118623479
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 268 KB
Volume: 3
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(05)81198-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Activity of Pertuzumab (rhuMAb

Clinical Activity of Pertuzumab (rhuMAb 2C4), a HER Dimerization Inhibitor, in Advanced Ovarian Cancer: Potential Predictive Relationship With Tumor HER2 Activation Status

✍ Gordon, M. S.; Matei, D.; Aghajanian, C.; Matulonis, U. A.; Brewer, M.; Fleming, 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 351 KB